Cambridge Investment Research Advisors
CTVA icon

Cambridge Investment Research Advisors’s Corteva CTVA Stock Holding History

Cambridge Investment Research Advisors’s Portfolio CTVA Stock Details CTVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.7M Buy
67,306
+10,290
+18% +$826K 0.01% 964
2026
Q1 		$4.77M Buy
57,016
+2,136
+4% +$161K 0.01% 994
2025
Q4 		$3.68M Buy
54,880
+2,020
+4% +$131K 0.01% 1097
2025
Q3 		$3.58M Buy
52,860
+544
+1% +$39.4K 0.01% 1105
2025
Q2 		$3.9M Buy
52,316
+2,939
+6% +$196K 0.01% 985
2025
Q1 		$3.11M Buy
49,377
+5,456
+12% +$337K 0.01% 1067
2024
Q4 		$2.5M Sell
43,921
-495
-1% -$29.3K 0.01% 1201
2024
Q3 		$2.61M Sell
44,416
-41,303
-48% -$2.26M 0.01% 1160
2024
Q2 		$4.62M Sell
85,719
-5,771
-6% -$318K 0.02% 798
2024
Q1 		$5.28M Buy
91,490
+42,046
+85% +$2.17M 0.02% 713
2023
Q4 		$2.37M Sell
49,444
-1,805
-4% -$86.1K 0.01% 1103
2023
Q3 		$2.62M Buy
51,249
+141
+0.3% +$7.47K 0.01% 977
2023
Q2 		$2.93M Buy
51,108
+1,056
+2% +$61.6K 0.01% 942
2023
Q1 		$3.02M Sell
50,052
-3,561
-7% -$217K 0.01% 895
2022
Q4 		$3.15M Sell
53,613
-5,143
-9% -$326K 0.02% 833
2022
Q3 		$3.36M Sell
58,756
-1,391
-2% -$81.1K 0.02% 761
2022
Q2 		$3.26M Sell
60,147
-91
-0.2% -$5.28K 0.02% 797
2022
Q1 		$3.46M Sell
60,238
-1,781
-3% -$91K 0.02% 833
2021
Q4 		$2.93M Sell
62,019
-108
-0.2% -$4.92K 0.01% 935
2021
Q3 		$2.61M Buy
62,127
+801
+1% +$34.7K 0.01% 944
2021
Q2 		$2.72M Sell
61,326
-3,761
-6% -$174K 0.01% 949
2021
Q1 		$3.03M Buy
65,087
+5,113
+9% +$226K 0.02% 796
2020
Q4 		$2.32M Buy
59,974
+1,431
+2% +$51.1K 0.01% 850
2020
Q3 		$1.69M Sell
58,543
-1,948
-3% -$54.8K 0.01% 892
2020
Q2 		$1.62M Buy
60,491
+428
+0.7% +$11.1K 0.01% 863
2020
Q1 		$1.41M Sell
60,063
-12,347
-17% -$340K 0.01% 806
2019
Q4 		$2.14M Sell
72,410
-11,351
-14% -$301K 0.02% 757
2019
Q3 		$2.35M Buy
+83,761
New +$2.42M 0.02% 682

Other funds holding CTVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Aristotle Capital Management
Aristotle Capital Management Los Angeles, California $47.7B AUM 13.92% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Cambridge Investment Research Advisors's CTVA Position: Q2 2026 in Review

Cambridge Investment Research Advisors increased its Corteva (CTVA) stake by 18% in Q2 2026, buying an estimated $826K and bringing the position to 67,306 shares worth $5.7M. The position accounts for 0.01% of the portfolio, ranked #964.

Cambridge Investment Research Advisors first reported a position in CTVA in Q3 2019 and has held it in 28 quarters since. 1,487 funds tracked by Wall St. Rank hold CTVA as of Q2 2026.

  • Cambridge Investment Research Advisors held 67,306 shares of Corteva worth $5.7M as of Q2 2026.
  • Cambridge Investment Research Advisors bought 10,290 Corteva shares in Q2 2026, an estimated $826K.
  • Corteva made up 0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #964 holding.
  • Cambridge Investment Research Advisors first reported a position in Corteva in Q3 2019 and has held it in 28 quarters since.
  • 1,487 funds tracked by Wall St. Rank held Corteva as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.